The Synthesis of Vicinal Amino Alcohols

/pdf/biosynthesis-and-mode-of-action-of-lantibiotics-4ckj6jz79p.pdf

Biosynthesis and mode of action of lantibiotics.

The genetic basis for the biosynthesis of large polypeptide antibiotics such as nisin has not been explained so far. We show here that the structural gene epiA encoding the antibiotic epidermin from Staphylococcus epidermidis is located on a 54-kilobase plasmid and codes for a 52-amino-acid prepeptide, which is processed to the tetracyclic 21-peptide amide antibiotic. The mature sequence of epidermin corresponds to the C-terminal 22-peptide segment of pre-epidermin and contains the precursor amino acids Ser, Thr and Cys, from which the unusual amino-acid constituents are derived. The more lipophilic epidermin is cleaved at a hydrophilic turn between Arg-1 and Ile+1 from the N-terminal segment-30 to -1, which probably assumes a partially amphiphilic alpha-helix conformation. We propose that the N-terminus (-30 to -1) plays a cooperative role during modification reactions and prevents toxicity of the mature epidermin to the producing strain before the antibiotic is cleaved off and secreted.

Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings

DNA gyrase is a type II topoisomerase that can introduce negative supercoils into DNA at the expense of ATP hydrolysis. It is essential in all bacteria but absent from higher eukaryotes, making it an attractive target for antibacterials. The fluoroquinolones are examples of very successful gyrase-targeted drugs, but the rise in bacterial resistance to these agents means that we not only need to seek new compounds, but also new modes of inhibition of this enzyme. We review known gyrase-specific drugs and toxins and assess the prospects for developing new antibacterials targeted to this enzyme.

/pdf/exploiting-bacterial-dna-gyrase-as-a-drug-target-current-586j1jrz1v.pdf

Exploiting bacterial DNA gyrase as a drug target: current state and perspectives.

We thank the Spanish Ministerio de Ciencia e Innovacion (Grant Nos. CTQ2007-65218 and Consolider Ingenio 2010-CSD-2007-00006 and CTQ2011-24165), the Generalitat Valenciana (Grant No. PROMETEO/2009/039 and FEDER), and the University of Alicante for generous and continuous financial support.

/pdf/diastereoselective-allylation-of-carbonyl-compounds-and-2yzd9tlqi5.pdf

Diastereoselective allylation of carbonyl compounds and imines: application to the synthesis of natural products.

The conventional determination of the amino-acid sequence of the peptide antibiotic Ro 09-0198 was prevented by four cyclizations via side chains. The joint application of NMR spectroscopy at highest field and automated Edman degradation yielded a complete determination of the connectivity pattern. The three-dimensional structure derived from NOE data exhibits an interesting separation of amino acids with hydrophilic and hydrophobic side chains.

The Structure of the Polycyclic Nonadecapeptide Ro 09-0198†

Complete Sequence Determination and Localisation of One Imino and Three Sulfide Bridges of the Nonadecapeptide Ro 09–0198 by Homonuclear 2D-NMR Spectroscopy. The DQF-RELAYED-NOESY-Experiment†

Cyclothialidine is a new DNA gyrase inhibitor isolated from Streptomyces filipinensis NR0484. Structurally, it belongs to a new class of natural products containing a unique 12-membered lactone ring that is partly integrated into a pentapeptide chain. Cyclothialidine was found to be one of the most active of all the DNA gyrase inhibitors tested in the DNA supercoiling reaction of Escherichia coli DNA gyrase; 50% inhibitory concentrations (in micrograms per milliliter) of 0.03 (cyclothialidine), 0.06 (novobiocin), 0.06 (coumermycin A1), 0.66 (norfloxacin), 0.88 (ciprofloxacin), and 26 (nalidixic acid) were found. In addition, DNA gyrases from gram-positive species were inhibited equally as well as DNA gyrase from E. coli. Cyclothialidine also inhibited the in vitro DNA replication directed from oriC of E. coli. Among the bacterial species tested, only Eubacterium spp. were inhibited by cyclothialidine, suggesting that it can enter the cells of Eubacterium and exert antibacterial activity through interference with the DNA gyrase within the cells, although its penetration into most bacterial cells appears to be poor. These results provide a basis for cyclothialidine to be a lead structure for novel antibacterial agents with DNA gyrase inhibitory activities. Images

Biological characterization of cyclothialidine, a new DNA gyrase inhibitor.

Sulfobacins A and B, novel von Willebrand factor (vWF) receptor antagonists, have been isolated from the culture broth of Chryseobacterium sp. (Flavobacterium sp.) NR 2993 by ethyl acetate extraction, and by Sephadex LH-20 and silica gel column chromatographies. The physico-chemical properties of the sulfobacins indicate that their structures are completely different from that of aurintricarboxylic acid, the one known vWF receptor antagonist. Sulfobacins A and B inhibit the binding of vWF to its receptor with IC50S of 0.47 and 2.2 microM, respectively. Sulfobacin A also inhibits ristocetin-induced agglutination in human platelets fixed with paraformaldehyde with an IC50 of 0.58 microM.

https://www.jstage.jst.go.jp/article/antibiotics1968/48/9/48_9_924/_pdf

Sulfobacins A and B, Novel von Willebrand Factor Receptor Antagonists: I. Production, Isolation, Characterization and Biological Activities

Tetrafibricin is a novel fibrinogen receptor antagonist produced by Streptomyces neyagawaensis NR0577. It was isolated from the culture broth by Diaion HP-21 adsorption, MeOH extraction, MCI GEL CHP-20P column chromatography, preparative HPLC and Toyopearl HW-40 SF column chromatography. The physico-chemical properties of tetrafibricin indicated that the structure of tetrafibricin is different from the known peptide fibrinogen receptor antagonists and closely related to the polyene macrolide antibiotics. Tetrafibricin strongly inhibited the binding of fibrinogen to its receptors with an IC50 of 46 nM. It also inhibited ADP-, collagen-, and thrombin-induced aggregation of human platelets with IC50s of 5.6, 11.0 and 7.6 microM, respectively.

Tsutomu Kamiyama

Papers

The Structure of the Polycyclic Nonadecapeptide Ro 09-0198†

Complete Sequence Determination and Localisation of One Imino and Three Sulfide Bridges of the Nonadecapeptide Ro 09–0198 by Homonuclear 2D-NMR Spectroscopy. The DQF-RELAYED-NOESY-Experiment†

Biological characterization of cyclothialidine, a new DNA gyrase inhibitor.

Sulfobacins A and B, Novel von Willebrand Factor Receptor Antagonists: I. Production, Isolation, Characterization and Biological Activities

Tetrafibricin, a novel fibrinogen receptor antagonist. I: Taxonomy, fermentation, isolation, characterization and biological activities